216 filings
Page 3 of 11
8-K
i51jt
7 Nov 19
Corcept Therapeutics Announces Third Quarter 2019 Financial Results and Provides Corporate Update
4:08pm
8-K
9a2nzs1
18 Sep 19
Corcept Therapeutics Appoints Kimberly Park to Board of Directors
8:28am
8-K
gfs77v8s kx6q
1 Aug 19
Corcept Therapeutics Announces Second Quarter 2019 Financial Results and Provides Corporate Update
4:10pm
8-K
vdn715y
20 Jun 19
Submission of Matters to a Vote of Security Holders
12:00am
8-K
x8qr5
11 Jun 19
Other Events
4:02pm
8-K
5in6k4xdpaprz2nix
9 May 19
Corcept Therapeutics Announces First Quarter 2019 Financial Results and Provides Corporate Update
4:11pm
8-K
w4czi e8kilqvzqk
25 Feb 19
Corcept Therapeutics Announces fourth quarter and full-year 2018 Audited Financial Results and provides corporate update
4:10pm
8-K
fpgfzuywr3 ega6a2
5 Feb 19
Regulation FD Disclosure
8:30am
8-K
ufp28n 4zfwh
31 Jan 19
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2018 Preliminary Selected Financial Results; Provides 2019 Revenue Guidance
4:10pm
8-K
nvo5e7016ii8 kfs
19 Nov 18
Departure of Directors or Certain Officers
9:00am
8-K
n6l4gfmlpgf00mts
1 Nov 18
Corcept Therapeutics Announces Third Quarter 2018 Financial Results and Provides Corporate Update
4:10pm
8-K
dh8pzab n6l7
9 Aug 18
Corcept Therapeutics Announces Second Quarter 2018 Financial Results and Stock Repurchase Program; Provides Clinical Update
4:10pm
8-K
lwfr n3xg4hof9j
7 Aug 18
Regulation FD Disclosure
4:10pm
8-K
d8bjex38hiu6r0yzvq1
4 Jun 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
e0ydhr84vlhj2x6u6x
8 May 18
Corcept Therapeutics Announces First Quarter 2018 Financial results and Provides Corporate Update
4:10pm
8-K
iawums8y
15 Mar 18
Corcept Therapeutics Files Lawsuit Against Teva Pharmaceuticals for Infringement of Korlym Patents
12:00am
8-K
xmjjrhe51w3uym
22 Feb 18
Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial
12:00am
8-K
51wb94i6cae3gbf4ub
5 Feb 18
Other Events
12:00am
8-K
bm17d5q 1y
1 Feb 18
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance
12:00am
8-K
an8z33t64qm60z9
17 Jan 18
Regulation FD Disclosure
12:00am